Abstract
BCC, cSCC and melanoma have very intense follow-up schedules, which are mostly based on expert opinion and on recurrence rates. We found that as the incidence of skin cancer rises it is followed by a three-to-eightfold larger number of follow-up consultations, depending on the type of skin cancer, which will seriously impact dermatological care capacity. A reconsideration and further evaluation of the follow-up schedules will be necessary to keep dermatological care accessible to all patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
